The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

In today’s fast-paced world, two seemingly separate health conditions, Polycystic Ovary Syndrome (PCOS) and Non-Alcoholic ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Discover How the Best Supplement for Fatty Liver Combines Milk Thistle, NAC, Choline & Turmeric to Support Liver Detox, Bile ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

ACG released new guidance for the management of malnutrition in patients with liver disease, including the newly renamed ...

Non-alcoholic fatty liver disease, now MASLD, is alarmingly prevalent among young, sedentary Indians. Studies reveal high ...

Rezdiffra™ (resmetirom) net sales of $137.3 million As of March 31, 2025, more than 17,000 patients on Rezdiffra Two-year compensated MASH cirrhosis (F4c) data from MAESTRO-NAFLD-1 trial selected as ...

FAT jabs can treat a liver disease affecting one in five people, a trial found. Semaglutide cut inflammation in two thirds of ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

According to a 2018 article, at least 25 percent of adults have metabolic dysfunction–associated steatotic liver disease (MASLD ... protect the liver from poor diet or excessive alcohol ...

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced six ...